# Lyra Therapeutics, Inc. (LYRA)

> Healthcare · US · Reports in USD

Fundamental indicators from Sponda, adjusted for inflation.

[HTML version](https://sponda.capital/en/LYRA/fundamentals)

## Annual figures

| Year | Revenue (M) | Net Inc. (M) | FCF (M) | Debt (M) | Equity (M) |
| --- | --- | --- | --- | --- | --- |
| 2025 | $ 407.5K | $ -29.61M | $ -29.67M | $ 30.26M | $ -10.72M |
| 2024 | $ 1.61M | $ -98.21M | $ -76.04M | $ 34.38M | $ 11.59M |
| 2023 | $ 1.68M | $ -67.77M | $ -69.58M | $ 26.88M | $ 89.42M |
| 2022 | $ 1.52M | $ -61.75M | $ -48.65M | $ 4.18M | $ 80.75M |
| 2021 | $ 338.8K | $ -51.72M | $ -34.71M | $ 1.45M | $ 34.32M |
| 2020 | $ 0 | $ -28.19M | $ -29.20M | $ 2.44M | $ 74.49M |
| 2019 | $ 0 | $ -21.05M | $ -18.03M | $ 3.33M | $ 7.33M |

Columns not available in this view: annualPriceMultiples, dividends. They require live market data and are shown on the HTML page instead.

## Leverage and liquidity

| Indicator | Value |
| --- | --- |
| Gross Debt / Eq | -2.82 |
| Liabilities / Eq | -4.37 |
| Current Ratio | 1.71 |

## Other views

- [Metrics](https://sponda.capital/en/LYRA.md)
- [Charts](https://sponda.capital/en/LYRA/charts.md)
- [Compare](https://sponda.capital/en/LYRA/compare.md)
- [Indicator definitions](https://sponda.capital/en/screener.md)

Data as of 2026-08-27.